NY State Senate Bill S6472

Archive: Last Bill Status - In Senate Committee Finance Committee

Introduced
In Committee
On Floor Calendar
- Passed Senate
- Passed Assembly
Delivered to Governor
Signed/Vetoed by Governor

Your Voice

Please enter your contact information

First Name *

Last Name *

Email Address *

A valid email address is required.

Home address search or enter your address manually *

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Leave this field blank

Actions

view actions (6)

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
May 31, 2018	reported and committed to finance
Jan 03, 2018	referred to health
Jun 21, 2017	recommitted to rules
Jun 14, 2017	ordered to third reading cal.1739 committee discharged and committed to rules
May 24, 2017	referred to health

Votes

view votes

May 31, 2018 - Health committee Vote

S6472

committee

Aye

Nay

Aye with Reservations

Absent

Excused

Abstained

Jun 14, 2017 - Rules committee Vote

S6472

committee

Aye

Nay

Aye with Reservations

Absent

Excused

Abstained

Co-Sponsors

view additional co-sponsors

S6472 (ACTIVE) - Details

See Assembly Version of this Bill:: A6906
Current Committee:: Senate Finance
Law Section:: Public Health Law
Laws Affected:: Amd §1370, Pub Health L
Versions Introduced in 2019-2020 Legislative Session:: S1028, A5779

S6472 (ACTIVE) - Summary

Relates to changing the definition of elevated blood lead levels from a blood lead level greater than or equal to ten micrograms of lead per deciliter of whole blood to five micrograms of lead per deciliter of whole blood.

S6472 (ACTIVE) - Sponsor Memo

 BILL NUMBER:  S6472

 TITLE OF BILL :  An act to amend the public health law, in relation
to the definition of elevated blood lead levels

 PURPOSE :

This bill will protect the health of children in New York State by
lowering the statutory standard for elevated blood lead levels to
reflect current scientific guidance.

 SUMMARY OF PROVISIONS :

Section 1: amends the definition of "elevated lead levels" set forth
in subdivision 6 of § 1370 of the Public Health Law to lower the level
of lead in whole blood requiring action under the Childhood Lead
Poisoning Prevention Program from the current level of 10 micrograms
of lead per deciliter of whole blood (pg/dL) to 5 pg/dL.  The section
also clarifies that the statutory authorization for the Department of
Health to establish a different blood lead level (BLL) by regulation
only permits it to establish a level lower than 5 pg/dL.

Section 2: provides that, within 90 days after this act takes effect,
the Department of Health shall adopt all necessary regulations to
define "elevated lead levels" to mean a BLL greater than or equal to 5
pg/dL of whole blood, or such lower BLL as the Department may

establish, to be utilized in its lead poisoning prevention program.
The Department is authorized to promulgate regulations on an emergency
basis to implement the provisions of this act.sill § 2 further
provides that, within 6 months after the date on which the U.S.
Department of Health and Human Services has published guidance
recommending a lower concentration of lead in blood than the
concentration established pursuant to § 1 of the bill as a reference
level for public health responses, the Department shall publish a
notice of proposed rule making to consider incorporating such guidance
into its regulations.

Section 3: sets an effective date for this act.

 JUSTIFICATION :

When the Legislature enacted the "Lead Poisoning Prevention Act" in
1992, it incorporated a recommendation issued by the U.S. Centers for
Disease Control (CDC). In 1991 the CDC had recommended a BLL of 10
pg/dL or greater as an action level for children and an advisory level
for environmental and educational intervention. In 2012, the CDC
lowered the recommended BLL to 5 pg/dL. Although the Department of
Health is authorized under the statute to prescribe a different level
by regulation, to date it has taken no action.

To set its recommendation, the CDC uses a reference value based on the
97.5th percentile of the BLL distribution among children 1 -5 years
old in the United States. As public health efforts continue, this
value is expected to decrease. The CDC reconsiders its recommendation
every four years, and is currently considering lowering its
recommended BLL to 3.5 pg/dL.

Lead is toxic and can cause neurological damage to children at any
level. The CDC has stated that no safe blood level in children has
been identified. Nevertheless, it still expects that children whose
blood tests higher than the reference level - that is, whose blood
level is higher than 97.5% of children in the U.S - should benefit
from a public health response. Blood test data from 2014 reported by
the CDC indicates that over 6000 children in New York City and almost
2000 children in other parts of the state had BLLs between 5 and 9
pg/dL.This bill will improve the State's efforts to protect children's
health and will ensure that any future changes in the CDC's
recommendations receive prompt consideration.

 LEGISLATIVE HISTORY :

New Bill

 FISCAL IMPLICATIONS :

None.

 EFFECTIVE DATE :
This act shall take effect immediately.

S6472 (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  6472

                       2017-2018 Regular Sessions

                            I N  S E N A T E

                              May 24, 2017
                               ___________

Introduced  by  Sens.  HANNON, JACOBS -- read twice and ordered printed,
  and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to the definition  of
  elevated blood lead levels

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Subdivision 6 of section 1370 of the public health law,  as
amended  by  chapter  485  of  the  laws  of 1992, is amended to read as
follows:
  6. "Elevated lead levels" means a blood lead  level  greater  than  or
equal  to  [ten] FIVE micrograms of lead per deciliter of whole blood or
such LOWER blood lead level as may  be  established  by  the  department
pursuant to rule or regulation.
  § 2. (a) Within 90 days after the date on which this act takes effect,
the department of health shall adopt all necessary regulations to define
"elevated  lead levels" to mean a blood lead level greater than or equal
to 5 micrograms per deciliter of whole blood, or such lower  blood  lead
level  as  the  department  may  establish,  to  be utilized in its lead
poisoning prevention program.   The department shall  be  authorized  to
promulgate regulations on an emergency basis to implement the provisions
of this act.
  (b)  Within 6 months after the date on which the federal department of
health and human services has published guidance  recommending  a  lower
concentration of lead in blood than the concentration established pursu-
ant  to section one of this act as the reference level for conducting an
environmental intervention, the department of  health  shall  publish  a
notice  of  proposed  rule  making to consider the incorporation of such
guidance into its regulations.
  § 3. This act shall take effect immediately.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD10663-01-7

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.

The New York State Senate

senate Bill S6472

Sponsored By

Archive: Last Bill Status - In Senate Committee Finance Committee

Your Voice

Actions

Votes

May 31, 2018 - Health committee Vote

Health Committee Vote: May 31, 2018

Jun 14, 2017 - Rules committee Vote

Rules Committee Vote: Jun 14, 2017

Co-Sponsors

S6472 (ACTIVE) - Details

S6472 (ACTIVE) - Summary

S6472 (ACTIVE) - Sponsor Memo

S6472 (ACTIVE) - Bill Text download pdf

Comments

senate Bill S6472

Share this bill

Sponsored By

Archive: Last Bill Status - In Senate Committee Finance Committee

Your Voice

Actions

Votes

May 31, 2018 - Health committee Vote

Health Committee Vote: May 31, 2018

Jun 14, 2017 - Rules committee Vote

Rules Committee Vote: Jun 14, 2017

Co-Sponsors

S6472 (ACTIVE) - Details

S6472 (ACTIVE) - Summary

S6472 (ACTIVE) - Sponsor Memo

S6472 (ACTIVE) - Bill Text download pdf

Comments